Language: 简体中文 English










您的位置: 首页 > 会议动态 > 正文

K. Rajender REDDY

University of Pennsylvania

更新时间:2019/1/9 14:55:26

K. Rajender REDDY

K. Rajender Reddy, MD, FAASLD

University of Pennsylvania

Philadelphia, PA

Dr. Reddy is professor of medicine in the Division of Gastroenterology at the University of Pennsylvania in Philadelphia, Pennsylvania. He is the director of hepatology and the medical director of liver transplantation at the University of Pennsylvania School of Medicine. 

Dr. Reddy received his medical education from Osmania Medical College in Hyderabad, India. He then completed a residency in internal medicine at New York Medical College Hospitals, a fellowship in gastroenterology at East Tennessee State University College of Medicine, and a fellowship in hepatology at the University Of Miami School Of Medicine. Subsequently, he joined the faculty at the University of Miami and in October 2001, Dr. Reddy moved to the University of Pennsylvania to his current position.

A fellow of the American College of Physicians and the American College of Gastroenterology, Dr. Reddy also is a member of the American Association for the Study of Liver Diseases and the American Gastroenterological Association. He has held several visiting professorships at medical schools throughout the world.

Dr. Reddy has authored or co-authored more than 270 peer-reviewed papers on a spectrum of hepatobiliary topics that include liver transplantation, chronic hepatitis C viral infection, HIV and the liver, and hepatocellular carcinoma. In addition, he has contributed to several textbooks, edited several books, and has participated in numerous scientific presentations at national and international meetings. He serves on the editorial boards of prestigious journals such as Liver Transplantation, Gastroenterology, and is an ad-hoc reviewer for several journals.

Dr. Reddy also has participated in a number of clinical trials that have advanced the understanding of the therapy of chronic viral hepatitis. He has been the recipient of both federal and non-federal funding for clinical research. His current research interests include liver transplantation, viral hepatitis, and hepatocellular carcinoma.